IBDEI20Q ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34241,2)
 ;;=^5009669
 ;;^UTILITY(U,$J,358.3,34242,0)
 ;;=M00.9^^131^1682^72
 ;;^UTILITY(U,$J,358.3,34242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34242,1,3,0)
 ;;=3^Pyogenic Arthritis,Unspec
 ;;^UTILITY(U,$J,358.3,34242,1,4,0)
 ;;=4^M00.9
 ;;^UTILITY(U,$J,358.3,34242,2)
 ;;=^5009693
 ;;^UTILITY(U,$J,358.3,34243,0)
 ;;=M00.00^^131^1682^78
 ;;^UTILITY(U,$J,358.3,34243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34243,1,3,0)
 ;;=3^Staphylococcal Arthritis,Unspec Joint
 ;;^UTILITY(U,$J,358.3,34243,1,4,0)
 ;;=4^M00.00
 ;;^UTILITY(U,$J,358.3,34243,2)
 ;;=^5009597
 ;;^UTILITY(U,$J,358.3,34244,0)
 ;;=M00.10^^131^1682^65
 ;;^UTILITY(U,$J,358.3,34244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34244,1,3,0)
 ;;=3^Pneumococcal Arthritis,Unspec Joint
 ;;^UTILITY(U,$J,358.3,34244,1,4,0)
 ;;=4^M00.10
 ;;^UTILITY(U,$J,358.3,34244,2)
 ;;=^5009621
 ;;^UTILITY(U,$J,358.3,34245,0)
 ;;=M86.20^^131^1682^62
 ;;^UTILITY(U,$J,358.3,34245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34245,1,3,0)
 ;;=3^Osteomyelitis,Subacute,Unspec Site
 ;;^UTILITY(U,$J,358.3,34245,1,4,0)
 ;;=4^M86.20
 ;;^UTILITY(U,$J,358.3,34245,2)
 ;;=^5014535
 ;;^UTILITY(U,$J,358.3,34246,0)
 ;;=M86.10^^131^1682^58
 ;;^UTILITY(U,$J,358.3,34246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34246,1,3,0)
 ;;=3^Osteomyelitis,Acute,Unspec Site
 ;;^UTILITY(U,$J,358.3,34246,1,4,0)
 ;;=4^M86.10
 ;;^UTILITY(U,$J,358.3,34246,2)
 ;;=^5014521
 ;;^UTILITY(U,$J,358.3,34247,0)
 ;;=M86.00^^131^1682^57
 ;;^UTILITY(U,$J,358.3,34247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34247,1,3,0)
 ;;=3^Osteomyelitis,Acute Hematogenous,Unspec Site
 ;;^UTILITY(U,$J,358.3,34247,1,4,0)
 ;;=4^M86.00
 ;;^UTILITY(U,$J,358.3,34247,2)
 ;;=^5014497
 ;;^UTILITY(U,$J,358.3,34248,0)
 ;;=M86.50^^131^1682^59
 ;;^UTILITY(U,$J,358.3,34248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34248,1,3,0)
 ;;=3^Osteomyelitis,Chronic Hematogenous,Unspec Site
 ;;^UTILITY(U,$J,358.3,34248,1,4,0)
 ;;=4^M86.50
 ;;^UTILITY(U,$J,358.3,34248,2)
 ;;=^5014607
 ;;^UTILITY(U,$J,358.3,34249,0)
 ;;=M86.30^^131^1682^60
 ;;^UTILITY(U,$J,358.3,34249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34249,1,3,0)
 ;;=3^Osteomyelitis,Chronic Multifocal,Unspec Site
 ;;^UTILITY(U,$J,358.3,34249,1,4,0)
 ;;=4^M86.30
 ;;^UTILITY(U,$J,358.3,34249,2)
 ;;=^5014559
 ;;^UTILITY(U,$J,358.3,34250,0)
 ;;=M86.8X9^^131^1682^63
 ;;^UTILITY(U,$J,358.3,34250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34250,1,3,0)
 ;;=3^Osteomyelitis,Unspec Sites
 ;;^UTILITY(U,$J,358.3,34250,1,4,0)
 ;;=4^M86.8X9
 ;;^UTILITY(U,$J,358.3,34250,2)
 ;;=^5014655
 ;;^UTILITY(U,$J,358.3,34251,0)
 ;;=M86.60^^131^1682^61
 ;;^UTILITY(U,$J,358.3,34251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34251,1,3,0)
 ;;=3^Osteomyelitis,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,34251,1,4,0)
 ;;=4^M86.60
 ;;^UTILITY(U,$J,358.3,34251,2)
 ;;=^5014630
 ;;^UTILITY(U,$J,358.3,34252,0)
 ;;=M86.40^^131^1682^56
 ;;^UTILITY(U,$J,358.3,34252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34252,1,3,0)
 ;;=3^Osteomyelitis w/ Draining Sinus,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,34252,1,4,0)
 ;;=4^M86.40
 ;;^UTILITY(U,$J,358.3,34252,2)
 ;;=^5014583
 ;;^UTILITY(U,$J,358.3,34253,0)
 ;;=R50.2^^131^1682^23
 ;;^UTILITY(U,$J,358.3,34253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34253,1,3,0)
 ;;=3^Fever,Drug-Induced
 ;;^UTILITY(U,$J,358.3,34253,1,4,0)
 ;;=4^R50.2
 ;;^UTILITY(U,$J,358.3,34253,2)
 ;;=^5019507
 ;;^UTILITY(U,$J,358.3,34254,0)
 ;;=R50.9^^131^1682^27
 ;;^UTILITY(U,$J,358.3,34254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34254,1,3,0)
 ;;=3^Fever,Unspec
